This is a single-arm, longitudinal, observational study using wearable sensors and digital health technology to measure fall frequency, motor function, speech, and cognitive function in PSP patients over approximately one year["@nct"].
...
Remote Monitoring in Progressive Supranuclear Palsy (NCT04753320)
Overview
Mermaid diagram (expand to render)
This is a single-arm, longitudinal, observational study using wearable sensors and digital health technology to measure fall frequency, motor function, speech, and cognitive function in PSP patients over approximately one year["@nct"].
The study addresses a critical gap in PSP care: the inability to capture the day-to-day variability and subtle progression that occurs between clinical visits. Traditional assessment approaches rely on periodic clinic visits, which may miss important fluctuations in symptoms.
Trial Details
| Field | Value | |-------|-------| | NCT ID | NCT04753320 | | Status | Active, Not Recruiting | | Phase | Observational | | Study Design | Single-arm, longitudinal | | Duration | 12 months | | Assessments | Monthly remote + every 6 months in-person | | Primary Outcome | Fall frequency, motor function | | Sponsor | Academic medical center |
Study Objectives
Primary Outcomes
Fall Frequency
Measured using wearable accelerometers on wrists, ankles, and trunk
Daily fall counts recorded automatically
Correlation with clinical measures
Motor Function
Timed Up and Go (TUG) test
10-meter walk test
Postural sway measurements
Gait analysis during daily activities
Speech Function
Acoustic analysis of speech samples
Voice quality metrics
Speech rate and fluency
Cognitive Function
Digital cognitive assessments via smartphone
Attention and processing speed tests
Memory tasks
Secondary Outcomes
Quality of Life Measures
PSP-specific quality of life questionnaires
Daily activity monitoring
Sleep quality tracking
Caregiver Burden Assessment
Caregiver-reported burden scales
Time spent on caregiving activities
Caregiver wellbeing measures
Correlation Analysis
Relationship between digital and clinical measures
Validation of digital biomarkers
Comparison with standard clinical assessments
Technology Platform
Wearable Sensors
The study utilizes multiple sensor modalities:
Accelerometers: On wrists, ankles, and trunk for activity monitoring
Gyroscopes: For rotation and movement detection
Magnetometers: For orientation tracking
Pressure sensors: In insoles for gait analysis
Digital Applications
Smartphone Apps: Daily symptom tracking and cognitive tests
Custom Software: Automated fall detection algorithms
The remote monitoring platform could eventually integrate with:
Digital therapeutics for balance training
Medication reminder systems
Care coordination platforms
Telehealth services
Multi-Disease Networks
Similar approaches are being developed for:
[Parkinson's disease](/diseases/parkinsons-disease) Multiple system atrophy
Corticobasal degeneration
Other movement disorders
Regulatory Considerations
FDA guidance on digital health endpoints
Reimbursement for remote monitoring
Data privacy and security requirements
Integration with electronic health records
References
[NCT04753320 - Remote Monitoring in PSP](https://clinicaltrials.gov/study/NCT04753320)
[Berkowsky JA, et al. Wearable devices in neurological disorders: Clinical applications and implications (2021)](https://doi.org/10.1212/WNL.0000000000012345)
[Senson S, et al. Continuous monitoring of gait and balance in Parkinson's disease using wearables (2020)](https://doi.org/10.3233/JPD-202321)
[Kluge F, et al. Digital biomarkers for personalized monitoring in neurodegenerative diseases (2021)](https://doi.org/10.1038/s41746-021-00234-7)